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Abstract
Phospoenolpyruvate carboxylase (PEPC) is absent from humans but encoded in the Plasmodium falciparum genome,
suggesting that PEPC has a parasite-specific function. To investigate its importance in P. falciparum, we generated a pepc
null mutant (D10Dpepc), which was only achievable when malate, a reduction product of oxaloacetate, was added to the
growth medium. D10Dpepc had a severe growth defect in vitro, which was partially reversed by addition of malate or
fumarate, suggesting that pepc may be essential in vivo. Targeted metabolomics using 13C-U-D-glucose and 13C-bicarbonate
showed that the conversion of glycolytically-derived PEP into malate, fumarate, aspartate and citrate was abolished in
D10Dpepc and that pentose phosphate pathway metabolites and glycerol 3-phosphate were present at increased levels. In
contrast, metabolism of the carbon skeleton of 13C,15N-U-glutamine was similar in both parasite lines, although the flux was
lower in D10Dpepc; it also confirmed the operation of a complete forward TCA cycle in the wild type parasite. Overall, these
data confirm the CO2 fixing activity of PEPC and suggest that it provides metabolites essential for TCA cycle anaplerosis and
the maintenance of cytosolic and mitochondrial redox balance. Moreover, these findings imply that PEPC may be an
exploitable target for future drug discovery.
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Introduction
Plasmodium falciparum is the causative agent of malaria, a disease
claiming an estimated 660,000 lives annually, primarily among
children in Africa [1]. The spread of drug resistance and the lack
of an efficacious vaccine hinder the control of the disease, and new
targets for chemotherapies or vaccine development need to be
identified and exploited [2]. The development of the parasite and
its modification of the host’s red blood cells (RBC) cause the
pathogenesis of malaria, but the biochemical adaptations enabling
this remain to be fully elucidated.
Energy generation in P. falciparum asexual erythrocytic stages
depends upon glucose being primarily converted to lactate by
anaerobic glycolysis, which is then excreted as the major metabolic
end product [3]. This is consistent with the finding that in P.
falciparum the pyruvate dehydrogenase complex (PDH) is solely
present in a plastid-like organelle, the apicoplast, where it provides
acetyl-CoA for fatty acid biosynthesis and possibly other acetylat-
ing reactions [4,5]. It was shown very recently, however, that
despite the absence of mitochondrial PDH, pyruvate can be
metabolised by a PDH-like enzyme complex [6] and oxidised
through a forward tricarboxylic acid (TCA) cycle in the erythro-
cytic stages of P. falciparum, being particularly important in
the gametocytes, and also in the related apicomplexan parasite
Toxoplasma gondii [3,6,7]. These findings are in contrast to previous
reports that there is no link between cytosolic glucose catabolism
and mitochondrial TCA metabolism [8], although this report was
later retracted [9].
A striking feature of carbon metabolism in Plasmodium is their
ability to fix CO2. This is utilised to generate carbamoyl phosphate
and thence pyrimidines and also is incorporated into amino acids
and a-ketoacids in P. lophurae, P. knowlesi and P. berghei [10–12].
Together with Trager’s finding that P. falciparum require CO2 for
in vitro growth [13], this suggests that CO2 fixation is necessary
for the parasite’s intra-erythrocytic survival. CO2 fixation may
occur via carbamoyl phosphate synthase, phosphoenolpyruvate
carboxylase (PEPC) and/or phosphoenolpyruvate carboxykinase
(PEPCK), with the latter two feeding into intermediary carbon
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metabolism [14–16]. P. falciparum PEPCK is primarily expressed in
gametocytes and mosquito stages [16], and is generally considered
to produce phosphoenolpyruvate (PEP) and release CO2. Thus
PEPC, which utilises bicarbonate, generated from CO2 by carbo-
nic anhydrase in P. falciparum [17], to convert PEP into oxalo-
acetate (OAA) is a strong candidate to have a key role in P.
falciparum carbon metabolism by fixing CO2. Plant and bacterial
PEPCs have been well characterised [18–20]; the malarial enzyme
has, however, been little studied. There is just one report on P.
berghei PEPC activity [14], even though PEPC is absent from
mammals and thus potentially offers great opportunities for
exploitation by novel antimalarial intervention strategies. Thus
this study aimed to confirm the operation of PEPC in erythrocytic
stages of P. falciparum, to elucidate its contributions to intermediary
carbon metabolism and intra-erythrocytic survival, and so
determine the likelihood that it is a viable drug target.
Results
Knockout of pepc gene by homologous recombination
Initially, a disruption of the pepc gene was attempted using a
single homologous recombination approach with the plasmids
pHH1-Dpepc and pHH1-39pepc. The control construct pHH1-
39pepc targeted the pepc locus and replaced the 39 region of the
gene, while the pHH1-Dpepc construct did not integrate into the
correct gene locus, as shown by pulsed field gel electrophoresis
(Fig. S1). These data revealed that the pepc locus is not refractory
to recombination, but that a gene disruption was unsuccessful
probably because the pepc gene is very important or essential for
parasite survival. Parasites were then transfected with the plasmid
pCC4-Dpepc, in order to target the pepc gene locus by double
homologous recombination [21]. The pepc locus was not targeted
when parasites were cultured in routine medium (which does not
contain added malate); however, addition of 5 mM malate to the
medium (malate medium) allowed the replacement of the gene
with the selectable marker, blasticidin deaminase (bsd). This was
verified by Southern blot analyses (Fig. 1). The D10Dpepc mutants
were cloned, and two independent clones D10Dpepc-1 and D10Dpepc-
2 (Fig. 1B) were used for phenotype analyses. The data for the two
clones were effectively the same, and so one set of data are
presented forthwith and the line referred to as D10Dpepc.
The pepc gene is important for intra-erythrocytic survival
of P. falciparum
Given that the deletion of the pepc gene was achieved only when
the culture medium was supplemented with 5 mM malate, the
effect of withdrawing malate from the medium on the growth of
D10Dpepc was analysed. Parasite growth in routine medium was
followed for 14 days (Fig. 2A). After 6 days in routine medium,
D10Dpepc had severely reduced growth rates and completely lost
their synchronicity. Nevertheless, they continued to replicate a
little, showing that in culture they are able to compensate to an
extent for the loss of PEPC function. Likely mechanisms include
obtaining some malate from the host erythrocyte directly or
conversion from fumarate, generated as a by-product of purine
salvage or itself taken up from the erythrocyte. The mutant
parasites grew better in medium supplemented with malate, but
the added 5 mM malate did not fully restore growth to the wild
type rate (Fig. 2A). Lower concentrations of malate were less
effective (Fig. 2B), whereas applying higher concentrations of
malate did not improve growth further (data not shown). The
beneficial effect of malate for growth of D10Dpepc seemed likely
to be due to providing the mutant parasite with one of the
downstream products of PEPC metabolism, and this post-
PEPC metabolism is important for progression of P. falciparum
through their erythrocytic cycle. In order to ascertain whether
other possible downstream metabolites of PEPC could have
beneficial effects, we tested several for growth stimulation of
D10Dpepc. The only metabolite other than malate that significantly
restored parasite growth was fumarate (Fig. 2C). This suggests that
supplementation of the medium with fumarate may also have
allowed experimental deletion of the pepc gene similarly to malate
supplementation, although this possibility was not tested. Notably
glutamine was unable to rescue growth, probably a reflection of
the parasite’s metabolism of this amino acid as described below.
Analysis of the pepc gene product
The predicted protein encoded by the pepc gene of P. falciparum
has clear similarity with PEPCs of other organisms but rather
limited identity. Amino acid identities between P. falciparum PEPC
and plant enzymes are in the range of 30% (those of Zea mays
and Arabidopsis thaliana are 29% and 31% identical, respectively)
whereas identity with Escherichia coli PEPC is 25%. An extension at
the N-terminus of the P. falciparum protein, a 29 amino acid central
insertion and a long insertion towards the C-terminus (see
alignment Fig. S2) are the prime reasons for this low degree
of sequence identity and also the larger mass of the parasite
protein (134 kDa compared with 100 kDa of bacterial PEPC and
116 kDa of plant PEPC) [18]. Nevertheless, the parasite protein
does contain residues known to be crucial to the activities of
other PEPCs. The C-terminal catalytic peptide at position 1143 to
1148 (equivalent to 966 to 970 of maize PEPC) (see Fig. S2) is
completely conserved in P. falciparum PEPC as are residues R685,
which is involved in PEP binding (equivalent to R647 in maize
PEPC), and H193 (equivalent to H177 in maize PEPC), which
acts as catalytic base in the active site of the protein [18]. In
addition, the two loops probably involved in regulation of PEPC
catalytic activity (loop I and loop II in Fig. S2) are also highly
conserved in P. falciparum PEPC. Loop I comprising residues
678GRGGXXG685RGG (XX=SV in P. falciparum PEPC; =TV
in maize PEPC) includes the active site residue R685 and allows
flexibility of this residue during the catalytic cycle. It is suggested
that in the maize enzyme when in its inactive state the equivalent
arginine residue is ‘attracted away’ from the active site, whereas in
the active state R685 is attracted to the active cavity through
interaction with the C-terminal glycine. Loop II is located at the
Author Summary
The genome of the human malaria parasite Plasmodium
falciparum encodes a protein called phosphoenolpyruvate
carboxylase (PEPC) absent from the human host. PEPC is
known to fix CO2 to generate metabolites used for energy
metabolism in plants and bacteria, but its function in
malaria parasites remained an enigma. Our study aimed to
elucidate the role and importance of PEPC in P. falciparum
in its host red blood cell by generating a gene deletion
mutant in P. falciparum. This was only achievable in the
presence of high concentrations of malate were added to
the culture medium. The mutant generated (D10Dpepc) had
a severe growth defect, which was rescued partially by
malate or fumarate (but not any other downstream
metabolites), suggesting that they feed into the same
metabolic pathway. Using heavy isotope labelled 13C-U-D-
glucose and 13C-bicarbonate we showed that PECP has an
important role in intermediary carbon metabolism and is
vital for the maintenance of cytosolic and mitochondrial
redox balance. Together these findings imply that PEPC
may be an exploitable target for future drug discovery.
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catalytic cavity and forms a bridge above the b-barrel; it is thought
to be involved in binding of HCO3
2 and may have a role in
covering the active site cavity to protect catalytic intermediates
from unwanted reactions with surrounding water [18]. Moreover,
a homology model of P. falciparum PEPC that was generated using
ITASSER (Fig. 3) is consistent with it having a good degree of
structural similarity with E. coli PEPC. This shows that the core
structure and the location of catalytically and regulatory amino
acids in P. falciparum PEPC are structurally in good agreement with
the equivalent in the PEPC of E. coli, with the b-barrel that
generates the active site cavity being structurally conserved and
similarly surrounded by a-helices. The homology model also
shows that the N-terminus of P. falciparum PEPC forms a non-
homologous loop (residues Met1 to Cys46 in Fig. 3). The two other
insertion regions also show clear differences in structure from the
E. coli PEPC, both being presented as surface-located loops (Fig. 3).
A full phylogenetic analysis of PEPCs was reported last year
[22] and this suggests that P. falciparum PEPC is aligned with the
C4 plant PEPCs as it possesses the signature amino acids K373
and S818; these are equivalent to K353 and S780 in the maize
PEPC sequence (Fig. S2), are invariably found in C4 plant PEPCs
and are thought to influence kinetic parameters and inhibition/
activation features of the enzymes. In contrast, these residues in
C3 plant PEPCs are arginine and alanine, respectively [23].
Scrutiny of other amino acid residues important for the protein’s
catalytic activity and binding of allosteric activators or inhibitors
[18,23,24] are consistent with this conclusion. Interestingly, how-
ever, P. falciparum PEPC does not possess the N-terminal serine
residue present in plant PEPC proteins that is phosphorylated in
order to regulate PEPC activity of C4 plants [19]. However,
analyses of the phosphoproteome of P. falciparum suggests that
S1109 is phosphorylated during blood stage development of the
parasites [25] which implies that P. falciparum PEPC activity may
be regulated through phosphorylation of this residue.
The conservation of all of these features in the P. falciparum
PEPC suggests that the gene encodes a functional PEPC protein.
Unfortunately detailed biochemical and structural analyses of
Plasmodium PEPC recombinant protein have so far been ruled out
by our lack of success in attempts to express parasite protein in
enzymatically active form; despite very extensive attempts using
different expression systems and modified gene constructs (with the
long insertions deleted), we have been unable to generate active
recombinant enzyme that could be studied in a meaningful way.
The native enzyme has been purified from P. berghei and displayed
a molecular size of 280 kDa [14], implying that it forms a
homodimer. Other larger PEPC species were also found after
sucrose gradient centrifugation, suggesting that similar to PEPC
isolated from other organisms the parasite enzyme may also form
a tetramer [18]. Such analyses of the PEPC of P. falciparum have
not been reported, obtaining sufficient pure enzyme has been
problematic.
Sensitivity of D10Dpepc to metabolic inhibitors
To probe the mechanism facilitating the survival of D10Dpepc, its
susceptibility to metabolic inhibitors was quantified. L-cycloserine,
a competitive inhibitor of pyridoxal phosphate-dependent en-
zymes such as aspartate aminotransferase (AAT) [26], showed a
clear differential effect on the parasite lines. D10Dpepc in routine
Figure 1. Gene replacement of pepc. (A) Schematic representation of the endogenous pepc locus, the pCC4-Dpepc plasmid and the pepc locus
following integration by double crossover recombination of pCC4-Dpepc (D10Dpepc). SpeI restriction sites for diagnostic Southern blot analyses and
sizes of the expected DNA fragments are indicated. Two regions homologous to the 59 (Dpepc 59) and 39 (Dpepc 39) end of pepc present in pCC4-
Dpepc recombine with the endogenous pepc locus and part of the pepc gene is replaced with the positive selectable marker blasticidin-S-deaminase
(bsd), which is under control of the calmodulin promoter (cam 59) and the histine rich protein 2 39 UTR (hrp2 39). The plasmid contains the negative
selectable marker cytosine deaminase (CD), which is under control of the heat shock protein 86 promotor (hsp86 59) and the P. berghei dihydrofolate
reductase 39 UTR (PbDT 39), and is lost upon double crossover recombination. (B) Southern blot of SpeI-digested genomic DNA of wild type parasites
and parasites transfected with pCC4-Dpepc, cultured in routine medium or malate medium, probed with the 59 end of pepc. Cycle 1 (c1) refers to the
first parasites resistant to blasticidin and 5-fluorocytosine (5-FC), while cycle 2 (c2) are 5-FC-resistant parasites after 1 additional drug selection cycle.
Integration of the plasmid only occurred when the transfectants were cultured in malate medium (diagnostic fragment: 5.0 kb). The derived clones
D10Dpepc-1 and D10Dpepc-2 are shown in lane 5 and 6. In routine medium no integration was observed, only fragments corresponding to endogenous
pepc (7.1 kb), plasmid (6.2 kb and 2.1 kb) and five fragments of unknown identity (*) were detected.
doi:10.1371/journal.ppat.1003876.g001
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medium was more sensitive (IC50 of 3061 mM compared to
10066 mM for D10, p,0.05; Fig. 4A), an effect partially reversed
when D10Dpepc was cultured in malate supplemented medium
(IC50 of 7063 mM). We analysed by western blotting the
expression levels of both AAT and malate dehydrogenase
(MDH), enzymes important for metabolism of OAA generated
by PEPC, and showed that they were not significantly affected by
the deletion of the pepc gene regardless of the presence or absence
of malate in the culture medium (Fig. S3). These data are entirely
consistent with D10Dpepc depending on the activity of aminotrans-
ferases such as AAT and being more sensitive to the competitive
inhibitor as result of lower OAA levels in the absence of PEPC.
AAT generates aspartate, which is a precursor for pyrimidine
synthesis. Therefore the parasites’ sensitivity to DSM190, an
inhibitor of the key enzyme of pyrimidine biosynthesis dihydroor-
otate dehydrogenase (DHOD) [27], was determined and it was
found that D10 and D10Dpepc were equally susceptible to the
inhibitor, regardless of the presence of malate (Fig. 4B), suggesting
that DHOD function is not affected in D10Dpepc. In the
mitochondrion, malate is converted to OAA by malate:quinone
oxidoreducatase (MQO) which transfers electrons to the mito-
chondrial electron transport chain (mtETC) [28] and so we
hypothesised that mtETC could be compromised by the absence
of PEPC. To address whether this was the case, the sensitivities to
atovaquone, an inhibitor acting against cytochrome bc1 complex
in the mtETC [29,30], were determined for D10 and D10Dpepc in
routine or malate medium. Atovaquone inhibited the parasite lines
with similar IC50 values between 0.7 and 1.2 nM (Fig. 4C). We
also compared the mitochondrial membrane potential of D10 and
D10Dpepc parasites by monitoring the uptake of the fluorophore
MitoTracker. The data acquired indicate that the electrochemical
gradient across the inner mitochondrial membrane is not affected
by the loss of PEPC function (Fig. S4). To confirm the validity
of this approach, the mitochondrial membrane potential was
collapsed with valinomycin; this resulted in an even distribution of
the fluorophore throughout the cytosol of the parasite.
Metabolomic analysis of D10Dpepc
The data above are consistent with PEPC generating OAA
through CO2 fixation with subsequent conversion into malate and
aspartate, and that these pathways are important for parasite
development. That both malate and fumarate restore the growth
phenotype implies that they feed into the same pathways. Inter-
mediary metabolism is, however, a complicated matrix of interac-
tions and the exogenously supplied malate and fumarate could
provide their beneficial effects via conversion to a number of
metabolites including OAA itself. So we decided that an analysis
of key metabolites in this part of metabolism would inform in
more detail on the contributions of PEPC. Thus a targeted
metabolomics analysis using liquid chromatography-mass spec-
trometry (LC-MS) with the stable-isotope labelled nutrients 13C-
U-D-glucose, 13C-bicarbonate and 13C,15N-U-glutamine was
conducted.
One difficulty in performing these labelling experiments was
that the growth defect of the mutant parasites restricted the
experiments that could be done. Whereas wild type D10 parasites
Figure 2. Growth phenotype of D10Dpepc and rescue by malate
and fumarate. (A) Growth of D10 in routine medium lacking malate
and D10Dpepc in malate or routine medium was followed for 14 days.
The cultures were diluted 1:5 on even days. The means 6 S.D. of two
(D10) and three (D10Dpepc) replicates are shown. (B and C) D10 and
D10Dpepc were cultured in routine medium for 9 days, synchronised,
diluted to 1% parasitaemia and cultured for 5 days in medium
supplemented with increasing concentrations of malate (0.5–5 mM) (B)
or a range of metabolites (C). The cultures were diluted 1:5 on day 3.
The parasitaemia on day 5 was determined and multiplied with the
dilution factor to give the accumulated parasitaemia. Data are means 6
S.E.M. of at least 3 independent experiments, each done in triplicate (for
succinate and citrate, means 6 S.D. of 2 experiments done in triplicate).
The asterisks indicate a statistically significant increase in parasitaemia
compared to routine medium (p,0.05). Other apparent changes were
not statistically significant. The final concentrations of metabolites used
in (C) were: 0.5 mM citrate, 5 mM all others.
doi:10.1371/journal.ppat.1003876.g002
Figure 3. I-TASSER homology model of P. falciparum PEPC.
Structural alignment of an I-TASSER predicted model for PfPEPC with
the top structural analogue EcPEPC is shown. PfPEPC is represented in a
ribbon diagram where a-helices are in green, b-sheets are in yellow and
coils are in grey. The EcPEPC ribbon diagram is represented completely
in blue. Coincident structures are dual-coloured. Based on the
homology modelling, three regions of PfPEPC were found not to
overlap with EcPEPC. Two of these regions are visible in (A), (Glu363 to
Ser391 and Gln954 to Gly1148). The structure rotated to the left is
displayed in (B) to show the third non-homologous region (Met1 to
Cys46). The C-terminus of PfPEPC appears to be entirely non-
homologous with EcPEPC presumably because of a long Plasmodium-
specific insertion (from Gln954) that separates the terminal 9 amino acid
sequence, which is highly conserved in the parasite protein, from the
core structure (Fig. S2).
doi:10.1371/journal.ppat.1003876.g003
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can be synchronised and maintained for the 28-hour incubation
period with the stable isotope at up to 10% parasitaemia, the
D10Dpepc mutant grown without added malate for 9 days only
reached a parasitaemia of 6%, maximally. In addition, these
parasites could not be concentrated efficiently using MACS
columns in the same way as the D10 parasites. The explanation for
this is unclear, but perhaps could reflect some disruption of
haemozoin synthesis in the mutant parasites. To overcome these
difficulties, we carried out direct comparisons of D10Dpepc- and
D10-infected RBC at 6% parasitaemia and, to ensure that the
data from these experiments were robust, we also analysed D10
parasites incubated under the same conditions but subsequently
concentrated to 90% parasitaemia via the MACS column
methodology [31].
Incubation of parasites with 13C-U-D-glucose led, as expected,
to an efficient incorporation of the 13C-labelled carbon skeleton
into glycolytic intermediates and the end product lactate, both
intracellularly and in the spent medium (Fig. 5, Table S1). The
pentose phosphate pathway (PPP) metabolites ribulose 5-phos-
phate/ribose 5-phosphate and sedoheptulose 7-phosphate were
also heavily labelled and apparently more abundant in D10Dpepc
compared with D10 (Figs. 5B, 5C), providing evidence that the
PPP is operational. In addition, levels of glycerol 3-phosphate
were also greatly increased in D10Dpepc and strongly labelled
(Figs. 5B, 5C). The proportion of incorporation of 13C label into
most of these metabolites was not apparently different in D10Dpepc
compared with D10, the only clear difference observed was
reduced incorporation of 13C label into sedoheptulose 7-
phosphate. Analysis of metabolites in the spent media of the
samples (Table S1) indicated a large reduction of lactate
production in D10Dpepc, reflecting a similar reduction in glucose
utilisation, signifying that the mutant parasites have a lower
metabolic capacity than D10. To confirm this and quantify the
relative generation of metabolic end-products and utilisation of
substrates fully (mass spectrometric analysis is only semi-quanti-
tative and is usually not used to quantify metabolite concentra-
tions, although it can give an indication), we determined the
concentrations of various metabolites in the spent media of the
different parasite lines using enzyme-based assays. The results
(Table 1) show that both the consumption of glucose and release of
lactate are reduced to approximately half in the D10Dpepc, and that
lactate apparently accounted for approximately 75% and 70% of
the glucose consumed by D10 and D10Dpepc, respectively. The
slightly lower relative generation of lactate by D10Dpepc is consistent
with some glucose being diverted into pathways other than only
glycolysis, such as the PPP and glycerol 3-phosphate production
(see Fig. 5).
D10 parasites also incorporated 13C label from glucose into
intracellular 13C-3-labelled malate, fumarate and aspartate, the
first two also being released into the medium, which can be
explained by 13C-3-labelled PEP being utilised by PEPC to fix
CO2 and form OAA (Fig. 5B). Most importantly, this was
confirmed by the finding that these metabolites were not labelled
in D10Dpepc, validating the activity of PEPC in generating them.
The presence of 13C in these metabolites was relatively greater in
the samples extracted from D10-infected RBC concentrated to
90% compared to those with 6% parasitaemia, whereas no 13C
label was detected in the RBC control (Fig. 5B), thus substantiating
that the incorporation was parasite-specific. The total levels of
malate, fumarate and aspartate were lower in D10Dpepc compared
to D10-infected RBC, in contrast to glycerol 3-phosphate and
the PPP metabolites (Fig. 5C). The release of malate and fumarate
into the spent medium by D10 parasites, although detected by the
mass spectrometric analysis, was less than we could measure using
our enzyme-based assays (5 and 33 mM, respectively) (Table 1),
emphasising that these metabolites are important in intermediary
carbon metabolism in the parasite rather than being metabolic
end-products (they could account for ,0.5% and ,2% of the
glucose used, maximally).
Interestingly, we also detected 13C-2- and 13C-5- labelled citrate
in D10, strongly supporting the presence of a canonical TCA
metabolism operating in the erythrocytic stages of P. falciparum at
least as far as citrate. Citrate was not 13C-labelled in D10Dpepc, thus
demonstrating that PEPC is a key node in intermediary carbon
metabolism and forms a crucial link between glycolysis and
mitochondrial TCA metabolism.
These findings using 13C-U-D-glucose were further validated
by the analyses of parasites incubated with 13C-HCO3
2 (Fig. 6,
Tables S3 and S4). The single 13C carbon present in bicarbonate
was detected in malate, fumarate and aspartate in D10, with
generally higher levels of incorporation detected in the samples
extracted from infected RBC with 90% parasitaemia. Importantly,
the incorporation of 13C label was completely absent in D10Dpepc-
infected RBC (the 13C label present in these samples was at a
similar level to that in the RBC control and attributed to natural
occurrence of 13C-1 isotopomers), confirming that CO2 fixation
into these metabolites is indeed attributable to PEPC. Overall
these data provide clear evidence that PEPC functions in CO2
fixation and has an anaplerotic role.
We also investigated the catabolism of 13C 15N-U-glutamine by
the parasites. The data obtained (Fig. S5 and Tables S5 and S6,)
showed that there was a good flux from glutamine, via glutamate,
to a-ketoglutarate and subsequently succinate, which were present
as 13C-5- and 13C-4-labelled molecules, respectively, in high
proportion. The amount of 13C-4-labelled succinate in the
D10Dpepc parasites was less than in D10, reflecting the lower cata-
bolic rate generally in the mutant and also the lower consumption
of glutamine (Table 1). There was, however, very little 13C label
Figure 4. Efficacy of L-cycloserine, DSM190 and atovaquone against D10 and the D10Dpepc in routine and malate media. The effect of
L-cycloserine (A), DSM190 (B) and atovaquone (C) on parasite viability. D10Dpepc was maintained for 9 days in routine medium prior to the experiment.
doi:10.1371/journal.ppat.1003876.g004
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detected in the malate and fumarate pools. This is consistent with
the conversion of succinate to these metabolites being rather low as
also described by others recently [6], although the dilution effect of
unlabelled forms of these metabolites in the host erythrocytes is
also a factor. This may also explain why added glutamine was
unable to restore growth of D10Dpepc, unlike malate and fumarate
(Fig. 2), although the mitochondrial location of the metabolites
generated from glutamine may also be an important factor.
These data for glutamine metabolism together with those
presented in Figs. 5 and 6 for metabolism of glucose and bicar-
bonate suggest that there is a full forward TCA cycle operating in
the parasites. However, there appear to be three separate segments
of the TCA pathway which are apparently fed by separate ‘entry
points’ (malate, pyruvate and a-ketoglutarate, respectively). The
fluxes through the reactions from malate and pyruvate to citrate as
well as that from a-ketoglutarate to succinate seem to be greater
than the flux through the other segments of the cycle. This could
be due to citrate and succinate being removed from the cycle and
fed into other metabolic activities, indeed citrate exiting the
mitochondrion could be part of the parasite’s malate shuttle as
discussed below.
Table 1. Metabolite concentrations in spent medium.
Metabolite RBC D10 D10Dpepc
Glucose (mM) 9.3560.40 7.3260.36 8.3860.16*
Lactate (mM) 0.3660.05 3.4760.29 1.7460.26**
Glutamine (mM) 1.5060.13 0.9660.11 1.5260.11**
Succinate (mM) ,0.006 ,0.006 ,0.006
Malate (mM) ,0.005 ,0.005 ,0.005
Fumarate (mM) ,0.033 ,0.033 ,0.033
All data are means of three independent experiments with standard deviations.
*: Glucose utilisation was significantly lower in D10Dpepc compared to D10 (p,
0.05).
**: Lactate excretion and glutamine utilisation were significantly lower in
D10Dpepc compared to D10 (p,0.001). Succinate, malate and fumarate
concentrations in the spent medium were below the detection limit of the
assay kits used.
doi:10.1371/journal.ppat.1003876.t001
Figure 5. Metabolite labelling from 13C-U-D-glucose. (A) Schematic representing glucose utilisation in P. falciparum based on the utilisation of
13C-U-D-glucose and distribution of 13C carbons into metabolic intermediates. (B) The parasites perform glycolysis such that triose 3-phosphates,
phosphoenolpyruvate (PEP) and lactate had very extensive labelling with 13C from 13C-U-D-glucose (all are three carbon compounds, hence exist
mainly as 13C-3 molecules as rapidly generated from glucose by glycolysis). 13C is also incorporated into malate, fumarate and aspartate through the
action of PEPC (and hence the 13C-3 molecules) as well as the TCA metabolite citrate by the action of a PDH-like enzyme [3,6] in D10 parasites. Citrate
is formed from OAA (occurring as 13C-3 molecule as well as unlabelled) and acetyl-CoA (presumably mainly 13C-2 molecules as generated from
pyruvate) and so was present as 13C-2 and 13C-5 molecules as well as unlabelled. 13C-labelled malate, fumarate, asparate and citrate were absent from
samples of D10Dpepc (Dpepc). 13C-U-D-glucose was also fed into the PPP intermediates ribulose 5-P/ribose 5-P and sedoheptulose 7-P (compounds
with 5 and 7 carbons, respectively, hence the extensive presence as 13C-5 and 13C-7 molecules) and used to generate glycerol 3-phosphate (also a 3-
carbon molecule hence the 13C-3 labelling). Legend: UL, unlabelled; 13C-1: one carbon atom labelled; 13C-2 to 13C-7: two to seven carbon atoms
labelled; D1090, D10-infected RBC concentrated to 90% parasitaemia; D106, D10-infected RBC at 6% parasitaemia. (C) Relative levels of intracellular
metabolites in D10Dpepc (Dpepc) and D10. Abbreviations: a-KG, a-ketoglutarate; DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde 3-
phosphate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PPM, parasite plasma membrane; PVM, parasitophorous vacuole membrane; QH2,
ubiquinol.
doi:10.1371/journal.ppat.1003876.g005
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Given the complex matrix of interconnections between different
areas of metabolism, it was conceivable that the deletion of pepc
would impact upon parts of metabolism in addition to redox
homeostasis and the TCA cycle and that these effects could
be contributing to the growth defect. Purine and pyrimidine
metabolism were candidate areas. Thus we analysed the mass
spectrometry data to find whether or not the levels of several
metabolites in this metabolic area are changed in the mutant
parasites. The results (Table S7, Fig. 5C) suggest that there are
relatively minor changes to carbamoyl aspartate, orotate, dihy-
droorotate and hypoxanthine, indicating that these pathways are
not greatly affected by the gene deletion.
PEPC as a possible drug target
The lack of PEPC in mammals and the importance of this
enzyme to P. falciparum, as this study confirms, makes the parasite
enzyme a possible drug target of interest. Plant and bacterial
PEPCs are inhibited by 3,3-dichloro-2-(dihydroxyphosphinoyl-
methyl) propenoate (DCDP), an analogue of PEP. DCDP has a
strong inhibitory effect on photosynthetic activity of plants at
1 mM and inhibits PEPC enzyme activity in the mM range [32].
The lack of recombinant protein has negated testing the effect
of this PEP analog on the activity of P. falciparum PEPC, but we
have assessed the efficacy of the inhibitor against parasite growth
in vitro. The IC50 value for the inhibition of D10 was found to be
10.660.9 mM (n= 5); given this high concentration required to
achieve a lethal effect on wild type parasites we did not test this
compound against the mutant line. This poor efficacy of DCDP is
likely to be due to its charged nature and thus to its inability to
penetrate the parasite membranes.
Discussion
Early studies with various Plasmodium species showed that
bicarbonate incorporation into intermediary metabolites poten-
tially involved TCA activity, suggesting a link between CO2
fixation and TCA anaplerosis in these parasites [10–12]. However,
subsequent analyses revealed that Plasmodium species lack typical
anaplerotic enzymes such as pyruvate carboxylase and malic
enzyme (providing OAA and malate, respectively, to the TCA
cycle in other organisms), and also mitochondrial aspartate:gluta-
mate antiporter and aminotransferase [33–35], all integral to the
malate shuttle in mammalian cells. Moreover, it was reported
and apparently accepted dogma that there was no link between
cytosolic glucose catabolism and mitochondrial TCA metabolism
[8,36], although the original paper has been recently retracted [9].
Therefore, to reconcile these reports we postulated and tested
the hypothesis that PEPC, a CO2 fixing enzyme usually found
in plants and bacteria, performs anaplerosis in erythrocytic P.
falciparum by maintaining a mitochondrial malate shuttle and
thereby performs an important metabolic function essential for the
growth of the parasite.
Our demonstration that the generation of D10Dpepc null mutants
was only possible in the presence of mM concentrations of malate
provides strong evidence that PEPC is indeed a critical enzyme
for providing malate via OAA for important metabolic reactions.
The severe growth defect of D10Dpepc in the absence of malate
and the partial rescue upon malate re-supplementation support
this conclusion. D10Dpepc survival in the absence of added malate
or fumarate is presumably mediated through salvage of these
metabolites from the host erythrocyte, although clearly the
availability is insufficient to rescue the severely limited growth of
Figure 6. Metabolite labelling from 13C-bicarbonate. (A) Schematic representing bicarbonate utilisation in P. falciparum by determining the
incorporation of the single 13C isotope into metabolic intermediates. (B) 13C-bicarbonate is incorporated into malate and fumarate and also to a lesser
extent into aspartate and citrate. The natural relative abundance of 13C-1 label in metabolites was not subtracted from the data shown. This accounts
for ,1.1% of 13C-1 for each carbon of the metabolites in all samples analysed including those of D10Dpepc (Dpepc) and RBC, which show no specific
additional incorporation of 13C-bicarbonate into their carbon skeleton. Thus the specific incorporation into the metabolites is most usefully assessed
by comparing the levels in parasite-infected cells with that measured in the RBC samples (which reflects the natural abundance of the isotope).
Abbreviations: as in Figure 5 and m, spent medium samples.
doi:10.1371/journal.ppat.1003876.g006
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D10Dpepc in culture (Fig. 2A). These data suggest that PEPC could
be essential for in vivo growth and viability of the parasites and
so potentially it is a valid drug target. Efforts have been made
to target PEPC in plants for development of a novel herbicide
[32,37] and our results suggest that such inhibitors are worth
considering for their antimalarial potential. We have tested a
commonly known PEPC inhibitor for its ability to inhibit P.
falciparum D10 viability and indeed this was possible, although
only at very high concentrations. This poor efficacy is likely to be
a reflection of the charged nature of the compound and it would
be interesting, therefore, to assess in future studies the efficacy
against P. falciparum of uncharged PEP analogues similar to those
previously described [37,38].
The availability of D10Dpepc has allowed us to investigate in
detail the contributions that the enzyme makes to intermediary
metabolism in the erythrocytic stages of the parasite. Using only
samples at 6% parasitaemia means that a large component of the
metabolites detected were from the erythrocytes themselves, which
effectively dilutes out labelling of the same metabolites present in
the parasites. Thus, we validated the data that we obtained with
low parasitaemia cultures by concentrating labelled D10-infected
RBC using the MACS procedure [31] and this reassuringly
provided similar data. More detailed analysis of intermediary
metabolism will require development of methodology allowing the
analysis of the D10Dpepc null mutants at higher parasitaemia.
The targeted metabolomics analysis of the parasite-infected
RBC, uninfected RBC and spent culture medium after incubation
with 13C-U-D-glucose and 13C-bicarbonate has provided defini-
tive evidence that PEPC produces OAA for the generation of
malate, fumarate and aspartate and feeds into mitochondrial
TCA metabolism. The proportion of the metabolites malate,
fumarate and aspartate 13C-labelled in the D10-infected RBC
was maximally ,20%, even in the samples obtained from
D10-infected RBC concentrated to ,90% parasitaemia. This
contrasts to the glycolytic and PPP intermediates and lactate that
were extensively labelled from 13C-U-D-glucose. There are several
contributory factors for this. Other substrates could feed into
the PEPC pathway, such as fumarate from purine salvage using
aspartate derived from haemoglobin digestion, and also OAA
generated by PEPC being converted to aspartate via AAT – the
idea of the latter being important is supported by the differential
inhibition of D10 and D10Dpepc by L-cycloserine. The involvement
of fumarate in post-PEPC metabolism is further supported by its
ability to partially rescue the growth defect of D10Dpepc (Fig. 2),
which also suggests that fumarate might be salvaged from the host
cell, and is in line with the finding that radiolabelled fumarate is
converted into malate, aspartate and OAA in isolated parasites
[39]. Similarly, exogenous malate clearly can be used and is
probably salvaged from the host erythrocyte, which could account
for the survival of D10Dpepc in the absence of malate supplemen-
tation. Malate and fumarate are known to be interconverted
in erythrocytes [40,41], thus either of them may be the main
metabolite salvaged, and it is probable that they are also inter-
converted by fumarase in the mitochondrion as this is generally a
reversible reaction. In addition, glutamine is another substrate
feeding into mitochondrial TCA metabolism, as shown here and
previously by MacRae and colleagues and Cobbold and colleagues
for P. falciparum and also T. gondii [3,6,7], leading to generation
of (unlabelled) fumarate and malate. Importantly, however, the
relatively high amounts of these metabolites in the RBC them-
selves are all unlabelled (Fig. 5, Table S1) and effectively dilute the
labelled proportion of these metabolites detected in infected RBC,
even in the concentrated samples of D10-infected RBC (Table S2).
The detection of 13C- malate and 13C-fumarate in the spent
medium of the 13C -U-glucose and 13C-bicarbonate experiments
with D10 parasites, and the absence of this from the spent medium
of D10Dpepc and RBC, also strongly supports the proposed activity
of PEPC (Tables S1, S3). The explanation for the release of these
metabolites requires further analysis, although our quantitative
data on metabolites in the spent media show clearly not only that
D10Dpepc has a catabolic deficiency reflecting its growth defect but
also that in both D10 and D10Dpepc the major route of glucose
catabolism is to lactate and there is very little release of succinate,
malate or fumarate (Table 1). Overall, the data suggest that,
as expected, there is a complicated interplay in intermediary
metabolism between the parasite and its host cell.
During asexual erythrocytic life, P. falciparum generates ATP
through glycolysis and primarily yields lactate as metabolic
end-product [36] and our data confirm this (Fig. 5; Table S1).
Importantly, our study corroborates the recent finding [3,6] that
an oxidative TCA pathway is also operational. The presence of
the 13C-2-labelled citrate suggests that acetyl-CoA is used in the
production of citrate in the mitochondrion, despite the lack of a
mitochondrial PDH [4] which in most eukaryotes catalyses acetyl-
CoA production in mitochondria, and supports the recent
suggestion that instead branched chain a-ketoacid dehydrogenase
acts to effect the conversion [3,6]. The additional occurrence of
13C-5-labelled citrate, which is absent in D10Dpepc, clearly supports
malate being an additional entry point for mitochondrial TCA
metabolism. This entry of malate into mitochondrial metabolism
also allows for the transfer of reducing equivalents into the mtETC
via MQO (Fig. 5).
The labelling pattern obtained with D10 and D10Dpepc-
infected RBC with 13C-U-D-glucose, 13C-bicarbonate and
13C,15N-U-glutamine has allowed us to construct a scheme of
the likely metabolic pathways operating in intermediary metab-
olism of asexual erythrocytic stages of P. falciparum and to postulate
how the D10Dpepc mutants have adapted to facilitate survival in
vitro. We propose (summarised in Fig. 7) that in wild type parasites
the OAA resulting from PEPC activity is converted to malate that
enters the mitochondrion where it is converted to OAA through
the action of MQO. The presence of a cytosolic MDH is well
established, a malate/ketoglutarate antiporter has been reported
and the presence of MQO is confirmed [28,42,43]. The OAA
generated probably can leave the mitochondrion, via a trans-
porter postulated previously [39,43], to complete an abbreviated,
parasite-specific, malate shuttle. An alternative possibility postu-
lated recently [6] is that it is citrate that exits the mitochondrion
and this is subsequently converted to OAA and acetyl-CoA by
citrate synthase II in a citrate lyase-like reaction, but there is no
experimental evidence available to date to support this suggestion.
Whichever of these happens, the shuttle leads to oxidation of cyto-
solic NADH, pivotal in maintaining cytosolic redox balance. The
importance of this shuttle itself rather than the TCA cycle per se is
emphasised by the finding that chemical ablation of the TCA cycle
using fluoroacetate, which inhibits the aconitase step and thus is
subsequent to OAA/citrate formation in the malate shuttle, had
no inhibitory effect upon growth of erythrocytic stages of the
parasite [3]. An additional factor is that the electrons transferred
into the mitochondrion through malate are passed into the
ubiquinone pool, which helps maintain mtETC. As the loss of
PEPC resulting in no flux into malate from glucose does not affect
the mtETC electrochemical gradient (Fig. S4) nor, apparently, the
activity of complex III or DHOD (Figs. 4,5C, Table S7), it seems
that the reduced contribution of MQO to the mtETC in these
erythrocytic stages of D10Dpepc can be compensated for by other
inputs. Our findings that there are elevated levels of both DHAP/
glyceraldehyde 3-phosphate and glycerol 3-phosphate in the
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mutants and that they are as strongly labelled with 13C in the
mutants as in D10, despite a reduced rate of glucose consumption,
could mean that there is an increased flux from glycolytic triose
phosphates to glycerol 3-phosphate. This is then potentially
converted back to triose phosphate via the mitochondrial glycerol
3-phosphate dehydrogenase [44] feeding electrons into mtETC
and so increasing flux, thereby compensating for the reduced flux
through MQO. This diversion of glycolytic flux would also result
in oxidation of NADH (in the conversion of triose phosphate to
glycerol 3-phosphate) and so help to compensate for the lack of
this occurring in the MDH step. Caution is required, however, in
interpreting the data so far, as the elevated levels of trioses in the
mutant parasites could reflect lower rates of their use rather than
elevated flux to them. Studies in recent years on the mtETC in
erythrocytic P. falciparum have indicated that it is more complex
than had been understood previously [29,30] and we suggest that
the pepc KO line that we have generated and characterised could
be an important tool with which to dissect this further.
Another result of the lack of malate generation from glucose and
the consequent reduction in malate feeding into TCA metabolism
would be a reduced flux through isocitrate dehydrogenase (IDH),
considered a major source of the generation of NADPH [45]. The
higher levels of ribulose 5-P/ribose 5-P in D10Dpepc, together with
the heavy labelling of the metabolite despite the lower glucose
utilisation, could reflect an increased flux through oxidative PPP,
which would result in elevated generation of NADPH, compen-
sating for the lower IDH flux. The finding that sedoheptulose 7-P
although apparently elevated in abundance is less heavily labelled
by 13C in D10Dpepc than in D10 itself could be due to the flux from
ribulose 5-P to sedoheptulose 7-P (transketolase activity) not being
similarly increased in D10Dpepc as is the flux through the oxidative
PPP and also that sedoheptulose 7-P is utilised less, neither of
which would necessarily impact upon redox homeostasis. Clearly,
however, more analyses will be required to fully elucidate the
adaptive changes of the mutant parasites.
Thus the modifications to metabolism that we have found in
the D10Dpepc mutant have provided a better understanding and
new insights into the crucial function of PEPC of P. falciparum. The
OAA generated by PEPC feeds into pathways central to main-
taining cytosolic redox balance (NADH oxidation by MDH) and
the mtETC (via MQO), and generating NADPH (via IDH) for
antioxidant and biosynthetic reactions. Together these are major
Figure 7. Hypothetical model of the contributions PEPC and adaptations of D10Dpepc to compensate for lack of PEPC. The width of
arrows is indicative of the fluxes through the pathways. Glucose used by wild type parasites is phosphorylated into glucose 6-phosphate, which is
either catabolised in the glycolytic pathway to generate lactate or is used in the PPP to provide NADPH and 5 and 7-carbon sugars for downstream
metabolic processes. During glycolysis, NAD+ reduction and NADH oxidation (blue boxes) are balanced in the complete glycolytic sequence itself, but
some metabolites are used in other ways. Glycerol 3-phosphate dehydrogenase and especially MDH, converting OAA (the product of CO2 fixation by
PEPC) to malate, play roles in maintenance of redox balance in the cytoplasm (red boxes). Pyruvate is metabolised not only into lactate but is also
transferred into the mitochondrion where it is oxidised into acetyl-CoA by a PDH-like dehydrogenase [3,6]. Malate is transferred into the
mitochondrion via a malate:a-ketoglutarate (aKG) antiporter and enters TCA metabolism leading to OAA formation in the organelle, this oxidation
transfers reducing equivalents into the mtETC (QH2). OAA may leave the mitochondrion, thus completing a parasite-specific form of a malate shuttle,
or be converted to citrate as part of canonical TCA metabolism. Deletion of pepc leads to an imbalance in redox metabolism in both cytosol and
presumably also mitochondrion. D10Dpepc apparently adapted to this with increased generation of glycerol 3-phosphate with concomitant NADH
oxidation, thus compensating partially for the loss of downstream generation of NAD+ through MDH. Increased flux through oxidative PPP is a
mechanism for generating NADPH which may be compensating for the reduced flux through TCA metabolism and therefore a reduced generation of
NADPH at the IDH step in D10Dpepc(purple boxes). The reduction in flux to lactate in D10Dpepc reflects the severely reduced growth phenotype of
D10Dpepc. The flux from glutamine via glutamate to a-ketoglutarate and, within the mitochondrion, to succinate and, at an apparently lower flux, to
fumarate and malate is shown, with a-ketoglutarate as an additional entry point into TCA metabolism. The flux through these metabolites is lower in
D10Dpepc compared with D10, reflecting the general growth defect of D10Dpepc and also its reduced consumption of glutamine, although the pathway
in which the carbon skeleton is incorporated is not dramatically affected.
doi:10.1371/journal.ppat.1003876.g007
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contributions to parasite intermediary and redox metabolism, and
our findings suggest that interfering with this could have major
repercussions for parasite survival in vivo, and consequently PEPC
inhibitors should be investigated as possible novel antimalarial
agents.
Materials and Methods
Materials
WR99210 was a kind gift from Jacobus Pharmaceuticals (USA).
5-Fluorocytosine (5-FC) was obtained from The Royal Infirmary
Pharmacy, Glasgow. Blasticidin was purchased from Invitrogen
(UK). Plasmids pHH1 and pCC4 were kind gifts from Professor A.
F. Cowman (The Walter and Eliza Hall Institute, Melbourne,
Australia). Human blood was obtained from the Glasgow Blood
Transfusion Services. Specific antibodies, used in western blot
experiments, were generated in rabbits using recombinant ex-
pressed protein (Eurogentec, Belgium). Secondary antibodies were
purchased from Promega. Anti-MDH and anti-AAT antibodies
were a kind gift from Professor H. Balaram (Jawaharlal Nehru
Centre for Advanced Scientific Research, Bangalore, India).
DSM190 was a kind gift from Professor M.A. Phillips (Department
of Pharmacology, University of Texas Southwestern Medical
Center, Dallas, USA). [8-3H]-hypoxanthine (specific activity: 10–
30 Ci/mmol) was from American Radiolabeled Chemicals. Other
chemicals were purchased from Sigma UK unless otherwise stated.
Generation of P. falciparum pepc knockout construct
The plasmid pCC4 [21] contains two homologous regions, to
both the 59 and 39 end of the target gene, and was used to generate
the pCC4-Dpepc knockout construct. The primers used to amplify
the 59fragment (1–498 bp of the pepc ORF) and the 39 fragment
(2440–2939 bp of the pepc ORF) are shown in Table S8. The
sequence of pCC4-Dpepc was verified (Eurofins MWG Operon).
Parasite culture, transfection, determination of IC50
values, parasite growth rate, and metabolite
concentrations in spent media
P. falciparum D10 (Papua New Guinea) was cultured according
to Trager and Jensen [13] in RPMI 1640 (Invitrogen, UK)
containing 11 mM glucose, 0.5% (w/v) Albumax II (Invitrogen,
UK), 200 mM hypoxanthine, 20 mg/ml gentamycin (PAA, UK)
(designated routine medium) in human erythrocytes between 0.5%
and 5% haematocrit. Parasite cultures were maintained under an
atmosphere of reduced oxygen (1% oxygen, 3% CO2 and 96%
nitrogen). Parasites were synchronised using sorbitol [46] and
freed from erythrocytes using saponin [47]. Parasitaemia was
determined using Giemsa-stained thin smears. Transfection of
into P. falciparum erythrocytic stages was performed as described
previously [48]. Transfectants were selected with 2.5 mg/ml
blasticidin and they were maintained in either routine medium
(which does not contain added malate) or routine medium
supplemented with 5 mM malate (malate medium). Before cloning
by limiting dilution according to Kirkman et al. [49], pCC4-Dpepc
transfectants were subjected to negative selection with 1 mM 5-FC.
Growth rates of D10 and D10Dpepc were determined as described
by Gu¨nther et al. [50]. For the rescue experiments, D10Dpepc were
cultured in routine medium for 9 days, synchronised, diluted to
1% parasitaemia and cultured for 5 days in routine medium or
routine medium supplemented with increasing concentrations of
malate (0.5 mM to 5 mM), 5 mM aspartate, 5 mM fumarate,
5 mM succinate, 5 mM glycerol, 5 mM glutamine or 0.5 mM
citrate. D10 were grown in the same media as controls. The
cultures were diluted 1:5 on day 3 and the parasitaemia of 1000
RBC was determined. The effects of L-cycloserine, DSM190 and
atovaquone on the viability of the parasites were determined by
measuring the incorporation of [3H]-hypoxanthine in the presence
of increasing drug concentrations according to Desjardins et al.
[51]. D10 and D10Dpepc were maintained in either routine
(D10Dpepc for 9 days) or malate medium and synchronised two
days prior to the experiment. IC50 values were calculated by
nonlinear regression of the sigmoidal dose-response equation using
GraFit version 7 (Erithacus, UK).
The concentrations of glucose, lacatate, glutamine, succinate,
malate and fumarate in the spent media from RBC, D10 and
D10Dpepc cultures were assayed using the following kits: glucose
(Megazyme D-Glucose-HK), lactate (Megazyme D-/L-Lactic Acid
(D-/L-Lactate) (Rapid)), glutamine (Megazyme L-Glutamine/
Ammonia (Rapid)), malate (Megazyme L-Malic Acid), succinate
(Megazyme Succinic Acid) and fumarate (Sigma Fumarate Assay
Kit). All assays were carried out as per manufacturer’s recom-
mendation.
Targeted metabolomics using 13C-metabolites
Targeted metabolomics was performed with D10 and D10Dpepc
cultured in routine medium for 9 days. After synchronisation,
the RBC number of D10 and D10Dpepc infected cultures was
determined using a Scepter 2.0 Handheld Automated Cell
Counter (Millipore, UK) and adjusted to 6% parasitaemia and
1% haematocrit with culture medium containing 13C-labelled
metabolites. Uninfected RBC of the same batch were used as
control at the same haematocrit. Either glucose, bicarbonate or
glutamine were replaced with 11 mM 13C-U- D-glucose (99%,
CK Gas Products Ltd., UK), 0.2% 13C sodium bicarbonate (99%,
CK Gas Products, UK) or 2 mM 13C, 15N-U-glutamine (99%, CK
Gas Products, UK), respectively, and cultures were incubated
for 28 h post-synchronisation. Spent medium was collected and
metabolites were extracted in HPLC-grade chloroform:methanol
(1:3 v/v). Metabolism of parasitized RBC was quenched to 4uC
using a dry ice/70% ethanol bath [52]. Infected RBC were
washed in ice-cold PBS and 3.56108 cells were used for metabolite
extraction using HPLC-grade chloroform:methanol:water (1:3:1
v/v/v). Samples were sonicated using a sonicating waterbath
and then metabolites extracted for 1 h at 4uC under shaking
conditions. The extracted samples were centrifuged at 16,000 g for
15 min at 4uC and the supernatants were transferred into glass
vials and stored at 280uC until LC-MS analysis. Late stage D10
cultures obtained 28 hours post-sorbitol synchronisation were
also enriched by magnetic purification using the Vario MACS
magnetic system and LS columns (Miltenyi Biotec) [31,53,54].
This procedure resulted in an accumulation of infected RBC to
90% and metabolites of 36107 infected RBC were analysed.
Liquid chromatography-mass spectrometry analyses
All samples were analysed using a liquid chromatography
(LC) mass spectrometry system (MS) (Ultimate 3000 LC
system, Dionex, UK, connected to an Exactive mass spectrometer,
Thermo Scientific, Germany). The LC system was controlled
using Chromeleon (Dionex, UK), and the MS was controlled by
the software Xcalibur (Thermo Scientific, Germany), which
allowed recording data for both positive and negative ionisation
mode. Separation of analytes was achieved via a ZIC-pHILIC
chromatography column (150 mm64.6 mm65 mm; Sequant,
Uema˚, Sweden) by a two solvent system consisting of solvent A:
20 mM ammonium carbonate and solvent B: acetonitrile. The
chromatography conditions are summarised in Table S9. Both
positive and negative mode spectra were acquired using 3
microscans over a scan range of 75.0–1200.0 m/z at a resolution
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of 50,000 (FWHM at 500 m/z) with an automatic gain control
(AGC) target of 16106 and a maximum inject time of
250 milliseconds. Specific instrument settings are supplied in the
supporting information.
Data analysis
Data processing initially involved centroiding and converting
vendor-specific raw LC-MS files into the mzXML open format.
Chromatographic peaks in these files were extracted using the
detection algorithm from XCMS [55] and stored in corresponding
PeakML files [56]. Subsequently, PeakML files representing
replicates were aligned and combined using mzMatch.R [57]
after filtering out all peaks that were not reproducibly detected.
The combined PeakML files were subjected to additional noise
filtering, gap-filling and metabolite identification steps, using
authentic metabolic standards for all metabolites of interest to
ensure reliable identification. The proportion of each metabolite
labelled with the stable isotopes was determined (see Figure S6)
together with information on the overall abundance of metabolites
present in the respective parasite extract samples or the culture
medium at the time of harvesting of the parasites. The PeakML
file obtained after filtering and identification was scanned for
labelled metabolites using the PeakML.Isotope.TargettedIsotopes
function of mzMatch-ISO [58]. Further details are provided in the
supporting information.
Genomic DNA and Southern blotting
Genomic DNA was isolated from saponin isolated parasites
using the QIAamp DNA Mini Kit (Qiagen, UK). 1–3 mg of
genomic DNA, digested with SpeI, were separated on a 0.8%
agarose gel and blotted onto positively charged nylon membrane
(GE Healthcare, UK). The blots were pre-hybridized and probed
at 55uC. Probes were labelled with thermostable alkaline phos-
phatase using the AlkPhos Direct Labeling and Detection System
(VWR, UK) and successive washes were performed according to
the manufacturer’s instructions at 55uC. The blots were exposed to
hypersensitive autoradiography film (VWR, UK) for 1–16 h.
Homology modelling of P. falciparum PEPC
Homology modelling of P. falciparum PEPC (PfPEPC) was
performed using the I-TASSER server for protein structure and
function prediction (http://zhanglab.ccmb.med.umich.edu/
I-TASSER/) [59,60]. The top three templates used for structure
prediction of PfPEPC were the PEPC from E. coli (EcPEPC) (PDB
entry 1JQN, [61]), PEPC from maize (ZmPEPC) (PDB entry
1JQO, [61]) and the archaeal-type PEPC (PDB entry 3ODM,
[62]). Root mean square deviation (RMSD) values showed
PfPEPC to be most similar to EcPEPC (0.56 A˚), followed by
ZmPEPC (2.49 A˚) and archaeal-PEPC (3.80 A˚). Based on these
templates, five I-TASSER models were obtained for PfPEPC
with C-scores ranging from 20.86 to 21.23. The structural align-
ment of the best model, that is, the model with the highest C-score
(20.86), with the top structural analogue, that is EcPEPC (0.56 A˚),
was generated using Magic Fit in Swiss-PDB Viewer 4.1.0 (http://
www.expasy.org/spdbv/) [63]. This is shown in Fig. 3.
Statistical analyses
See supporting information for details.
Supporting Information
Figure S1 Gene disruption and 39 replacement of
pepc by the pHH1 plasmid. (A) Schematic diagram of
the endogenous pepc gene locus in D10 wild type parasites, the
pHH1-Dpepc plasmid and the recombined pepc locus following
single cross over recombination between the plasmid and an
1113 bp region of pepc (D10Dpepc). The plasmid contains a human
dihydrofolate reductase (hDHFR) selectable marker under control of
the P. falciparum calmodulin promoter (cam 59) and flanked by the
P. falciparum histidine rich protein 2 terminator (hrp2 39), a region
homologous to pepc (Dpepc), an artificial 39 UTR (P. berghei
dihydrofolate reductase/thymidylate synthase 39UTR, PbDT 39) and an
artificial stop codon (Stop*). AccI restriction sites and sizes of the
resulting diagnostic DNA fragments are indicated (in bold). (B)
Similar scheme for the integration of the pHH1-39pepc plasmid,
resulting in D1039pepc, which includes a functional pepc gene.
Diagnostic NspI sites and resulting fragment sizes are indicated.
(C) Two independent Southern blots of D10 and D10Dpepc, probed
with the Dpepc DNA fragment. c2 and c3 refer to the WR selection
cycles, in which the parasites are grown without drug for 3 weeks
and then subjected to WR selection. Plasmid (6.9 kb) is absent and
seemed to be integrated in cycle 2 and 3 (D10Dpepc c2 and D10Dpepc
c3). However, only the 2.9 kb integration fragment is present. The
5.7 kb fragment is not detected, but instead a fragment of,4 kb is
present. Endogenous pepc (1.8 kb) is present in all D10Dpepc lines
and D10. (D) Southern blot of pHH1-39pepc, D10 and D1039pepc,
probed with the 39pepc DNA fragment. Integration fragments (2.3
and 4.4 kb) and the fragment corresponding to pHH1-39pepc
(1.2 kb) are detected in D1039pepc c1. The fragment indicative of
endogenous pepc (5.5 kb) has disappeared, but is visible in D10. (E)
Pulse field gel electrophoresis of D10, D10Dpepc and D1039pepc. In
the left panel, the ethidium bromide-stained gel, indicating
chromosomes 11 to 14, is shown. In the right panel, the southern
blot is shown, probed with either the Dpepc DNA fragment or the
hDHFR DNA fragment. The Dpepc probe detects integration of the
pHH1- Dpepc plasmid or endogenous pepc, which is located on
chromosome 14 and present in all lines. A signal is also present in
the band representing chromosomes 1–10, indicative of random
integration of pHH1- Dpepc (D10Dpepc c2 and D10Dpepc c3). This is
confirmed with the hDHFR probe, which also detects integration
of the pHH1- Dpepc plasmid in the smaller chromosomes. The
pHH1-39pepc plasmid did integrate in the correct gene locus on
chromosome 14 (D1039pepc c2).
(TIF)
Figure S2 ClustalW alignment (1.83) multiple sequence
alignment. CLUSTAL W (1.83) multiple sequence alignment.
(*), identical residues; (:), strong conservation between replaced
amino acids; (.), weak conservation between replaced amino acids;
(-), gaps to maximise alignment; bold red letters: active site
residues; bold blue letters: residues involved in binding of hexose
6-phosphate; bold green letters: determinants that distinguish C4
or C3 plant PEPCs; N-terminal blue blocked: site of phosphor-
ylation of plant PEPCs – the serine residue is absent from P.
falciparum PEPC and E. coli PEPC; C-terminal blue blocked:
unique, parasite-specific serine residue found to be phosphorylated
in phosphoproteome of P. falciparum; green blocked: Loop I and II
both involved in catalytic activity; yellow blocked: C-terminal
catalytic peptide. At, Arabidopsis thaliana PEPC 3 (NP_188112);
Ec, Escherichia coli PEPC (B7MR83); Fp, Flaveria pringlei PEPC
(Q01647); Ft, F. trinervia (P30694); Pf, P. falciparum PEPC
(PF3D7_1426700); Zm, Zea mays PEPC (ACJ38542).
(DOCX)
Figure S3 Western blot analyses of expression of MDH
and AAT. The left panel (A) shows representative western blots
of 10 mg parasite extract of D10 and two clones of D10Dpepc
(D10Dpepc-1 and D10Dpepc-2), either in malate or routine medium,
with antibodies against (A) MDH (34 kDa) or (B) AAT (42 kDa).
Role of Plasmodium falciparum PEPC
PLOS Pathogens | www.plospathogens.org 11 January 2014 | Volume 10 | Issue 1 | e1003876
D10Dpepc- 1 and D10Dpepc-2 routine were cultured in routine
medium for 9 days prior to the extraction. The loading control is
an antibody against 2-Cys peroxiredoxin (2-CP, 22 kDa) and is
shown underneath each blot. The right panel (B) shows the
respective graphs (mean 6 S.E.M.) of the densitometry analyses of
3 or 4 independent extracts. Relative protein expression was
calculated by comparing the intensity of the MDH or AAT bands
with the 2-CP loading control, normalised to D10.
(TIF)
Figure S4 Mitochondrial membrane potential of D10
and D10Dpepc. Themitochondrial membrane potential was assessed
by the accumulation ofMitoTracker Red CMXRos (red fluorescence)
and is shown in the right panel together with a nuclear stain (Hoechst
33258, blue fluorescence). DIC images of the live cells are shown in
the left panel. D10Dpepc was cultured in routine medium for 9 days and
as control for a collapsed mitochondrial membrane potential, D10
was pre-treated with 500 nM valinomycin (bottom panel).
(TIF)
Figure S5 Labelling of D10 and D10Dpepc with 13C,15N-U-
glutamine. (A) Schematic representation of glutamine utilisation
in P. falciparum based on the utilisation of 13C,15N-U-glutamine
and distribution of 13C carbons into some major metabolic
intermediates of the TCA cycle. (B) The parasites use glutamine to
generate a-ketoglutarate (13C-5-labelled), which is translocated
into the mitochondrion, where it is converted to succinate (13C-4-
labelled). The flux into fumarate and malate is apparently low and
only small amounts of fumarate (13C-4-labelled) and malate (13C-
4-labelled) are detectable.
(TIF)
Figure S6 Analysis of metabolite labelling with 13C-
isotopes. The schematic shows the abundance of different
species of a hypothetical metabolite containing 6-carbons after
extraction from a biological sample. Open circles display
unlabelled (12C) carbon, red-filled circles represent 13C- carbon.
Peak shapes and area were assessed and retention times confirmed
manually before relative incorporation of heavy isotopes into the
metabolite was calculated from the peak areas of each labelled
metabolite species as shown in A. Natural abundance of 13C-
1species is represented by the bar in the 113C column in A and the
relative proportions of the metabolite containing different numbers
of 13C atoms was calculated and displayed as shown in B.
(TIF)
Table S1 Peak areas of selected metabolites after
labelling infected RBC (6% parasitaemia) with 13C-U-
L-glucose. Parasitaemia was 6%, labelling was performed for
28 h before cells were harvested and metabolites extracted. Shown
are the peak areas calculated from the negative ionisation mode
obtained by LC-MS. RBC, D10 wild type and D10Dpepc as well as
spent media of all three cell types were analysed in this
experiment. The data represent three biological replicates.
(XLS)
Table S2 Peak areas of selected metabolites after
labelling infected RBC (90% parasitaemia) with 13C-U-
L-glucose. Parasitaemia was 90%, labelling was performed for
28 h before RBC and D10-parasitised RBC were harvested and
metabolites extracted. Shown are the peak areas calculated from
the negative ionisation mode obtained by LC-MS. The data
represent three biological replicates.
(XLS)
Table S3 Peak areas of selected metabolites after
labelling infected RBC (6% parasitaemia) with
13C-bicarbonate. Parasitaemia was 6%, labelling was per-
formed for 28 h before cells were harvested and metabolites
extracted. Shown are the peak areas calculated from the negative
ionisation mode obtained by LC-MS. RBC, D10 wild type and
D10Dpepc as well as spent media of all three cell types were analysed
in this experiment. The data represent three biological replicates.
(XLS)
Table S4 Peak areas of selected metabolites after
labelling infected RBC (90% parasitaemia) with 13C-
bicarbonate. Parasitaemia was 90%, labelling was performed
for 28 h before RBC and D10-parasitised RBC were harvested
and metabolites extracted. Shown are the peak areas calculated
from the negative ionisation mode obtained by LC-MS. The data
represent three biological replicates.
(XLS)
Table S5 Peak areas of selected metabolites after
labelling infected RBC (6% parasitaemia) with 13C,
15N-U-glutamine. Parasitaemia was 6%, labelling was per-
formed for 28 h before cells were harvested and metabolites
extracted. Shown are the peak areas calculated from the negative
ionisation mode obtained by LC-MS. RBC, D10 wild type
and D10Dpepc as well as spent media of all three cell types were
analysed in this experiment. The data represent three biological
replicates.
(XLSX)
Table S6 Peak areas of selected metabolites after
labelling infected RBC (90% parasitaemia) with 13C,
15N-U-glutamine. Parasitaemia was 90%, labelling was per-
formed for 28 h before RBC and D10-parasitised RBC were
harvested and metabolites extracted. Shown are the peak areas
calculated from the negative ionisation mode obtained by LC-MS.
The data represent three biological replicates.
(XLSX)
Table S7 Peak areas of pyrimidine biosynthesis inter-
mediates and purines after labelling infected RBC (6%
parasitaemia) with 13C-bicarbonate or 13C, 15N-U-gluta-
mine. Parasitaemia was 6%, labelling was performed for
28 h before cells were harvested and metabolites extracted.
Shown are the peak areas calculated from the negative ionisation
mode obtained by LC-MS. In both experiments, labelled and
unlabelled datasets were generated and analysed by LC-MS.
The data represent D10 (D10 unlabelled), D10-Lab (D10
labelled with heavy isotope metabolites), PEPCKO (D10Dpepc
(unlabelled), and PEPCKO-Lab (D10Dpepc labelled with heavy
isotope metabolites). The data represent three biological
replicates.
(XLSX)
Table S8 Primers used in this study. Restriction sites are
shown in bold letters.
(DOCX)
Table S9 Chromatography conditions LC-MS. The de-
tailed profile of the solvents used for the chromatography elution.
(DOCX)
Text S1 Supporting materials and methods and refer-
ences.
(DOCX)
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